Serum 2-Hydroxyglutarate Production in <i>IDH1</i>- and <i>IDH2</i>-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Maxime Janin(Centro de Investigación Biomédica en Red de Cáncer), Stéphane de Botton(Université Paris-Saclay), Jean‐Baptiste Micol(Université Paris-Saclay), Élisabeth Chachaty(Hôpital Necker-Enfants Malades), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Elena Mylonas(Hôpital Necker-Enfants Malades), Éric Solary(Inserm), Serge Koscielny(Institut Gustave Roussy), Nathalie Auger(Institut Gustave Roussy), Véronique Saada(Université Paris-Saclay), Robert Barouki(Inserm), Cécile Pautas(Centre Hospitalier Universitaire Henri-Mondor), Laurianne Scourzic(Hôpital Necker-Enfants Malades), Cyril Quivoron(Inserm), Chris Ottolenghi(Hôpital Necker-Enfants Malades), Sébastien Forget(Hôpital Necker-Enfants Malades), Olivier Bernard(Université de Poitiers), Aline Renneville(Université Paris-Sud), Frank Griscelli(Inserm), Denis Caillot, Annelise Bennaceur‐Griscelli(Inserm), Edwige Leclercq(Hôpital Necker-Enfants Malades), Céline Berthon(Université Paris-Sud), Virginie Penard‐Lacronique(Université Paris-Sud), Hervé Dombret(University of London Institute in Paris), Daniel Rabier(Hôpital Necker-Enfants Malades), Marie-Hélène Courtier(Hôpital Necker-Enfants Malades)
Cited by 117
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k